http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 12 Jun 2026 13:24:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html si-local-file:///var/storage/secattach/20260612/26639909.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html Fri, 12 Jun 2026 13:24:00 -0400 CRMD O.08513169 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html si-local-file:///var/storage/secattach/20260612/26639909.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639909.html Fri, 12 Jun 2026 13:24:00 -0400 CRMD O.08513169 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html si-local-file:///var/storage/secattach/20260612/26639857.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html Fri, 12 Jun 2026 13:07:00 -0400 CRMD O.08513169 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html si-local-file:///var/storage/secattach/20260612/26639857.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+SHAIBATALHAMD+AYMEN+ABDALKADER/26639857.html Fri, 12 Jun 2026 13:07:00 -0400 CRMD O.08513169 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html si-local-file:///var/storage/secattach/20260608/26614889.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html Mon, 08 Jun 2026 08:45:00 -0400 CRMD O.08513169 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html si-local-file:///var/storage/secattach/20260608/26614889.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CorMedix+Inc.+++++++++++++For%3A+Jun+08/26614889.html Mon, 08 Jun 2026 08:45:00 -0400 CRMD O.08513169 http://www.streetinsider.com/Litigation/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html <p>The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling that upholds CorMedix Therapeutics' (NASDAQ: CRMD) patents for Minocin for Injection and finds Nexus Pharmaceuticals infringed those patents.</p><p>The Federal Circuit decision upheld a 2023 district court ruling from the U.S. District Court for the Northern District of Illinois following a four-day bench trial. The lower court had found in favor of CorMedix's subsidiary Melinta Therapeutics on patent infringement and validity issues.</p><p>The appeals court rejected Nexus Pharmaceuticals' challenge to the patent validity and affirmed a permanent injunction preventing Nexus from marketing its generic minocycline product before the http://www.streetinsider.com/Litigation/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html Mon, 08 Jun 2026 08:32:40 -0400 CRMD http://www.streetinsider.com/Corporate+News/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html <p>The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling that upholds CorMedix Therapeutics' (NASDAQ: CRMD) patents for Minocin for Injection and finds Nexus Pharmaceuticals infringed those patents.</p><p>The Federal Circuit decision upheld a 2023 district court ruling from the U.S. District Court for the Northern District of Illinois following a four-day bench trial. The lower court had found in favor of CorMedix's subsidiary Melinta Therapeutics on patent infringement and validity issues.</p><p>The appeals court rejected Nexus Pharmaceuticals' challenge to the patent validity and affirmed a permanent injunction preventing Nexus from marketing its generic minocycline product before the http://www.streetinsider.com/Corporate+News/CorMedix+wins+federal+appeals+court+ruling+on+Minocin+patent+case/26614812.html Mon, 08 Jun 2026 08:32:40 -0400 CRMD http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Press+Releases/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html <p align="justify">PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product MINOCIN® for Injection are valid and infringed by the product developed by Nexus Pharmaceuticals, Inc.</p> <p align="justify">Following a four-day bench trial in 2023, the district court found in favor of CorMedix’s wholly owned subsidiary Melinta Therapeutics on all patent infringement and validity issues. The Federal Circuit’s decision on Friday upheld http://www.streetinsider.com/Globe+Newswire/U.S.+Court+of+Appeals+for+the+Federal+Circuit+Affirms+Victory+for+Cormedix+Therapeutics+in+Minocin%C2%AE+Patent+Litigation/26614764.html Mon, 08 Jun 2026 08:30:00 -0400 A.50114033 CRMD O.08513169 O.22806100 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26500207.html si-local-file:///var/storage/secattach/20260515/26500207.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26500207.html Fri, 15 May 2026 08:40:00 -0400 CRMD O.08513169 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26500207.html si-local-file:///var/storage/secattach/20260515/26500207.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++CorMedix+Inc.++++++++++++++++++++++++++Filed+by%3A+Deep+Track+Capital%2C+LP/26500207.html Fri, 15 May 2026 08:40:00 -0400 CRMD O.08513169 http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537 http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537 http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537 http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Press+Releases/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537 http://www.streetinsider.com/Globe+Newswire/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537 http://www.streetinsider.com/Globe+Newswire/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537 http://www.streetinsider.com/Globe+Newswire/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html <p align="justify">PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td colspan="2"><strong>RBC Capital Markets Global Healthcare Conference </strong><br/></td></tr><tr><td style="max-width:8%; width:8%; min-width:8%;">Date:</td><td style="max-width:92%; width:92%; min-width:92%;">Wednesday, May 20, 2026</td></tr><tr><td>Time:</td><td>11:00am EDT</td></tr><tr><td>Webcast:</td><td><a target="_blank" href="https://kvgo.com/rbc/cormedix-inc-may-2026" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/Cormedix+Therapeutics+to+Participate+in+two+Upcoming+Investor+Conferences/26500072.html Fri, 15 May 2026 08:30:00 -0400 A.50216777 CRMD O.08513169 O.54516537